G Kishan Reddy says Centre will try its best to promote pharma sector in Hyderabad
Hyderabad: The Pharma sector should be encouraged and government in the coming days will try its best to promote the sector, said Union Minister For Coal and Mines, G Kishan Reddy.
The Telangana BJP President was the Chief Guest at the Indian Pharmaceutical Congress (IPC) Expo which was held at Hi-Tech Exhibition Centre Hall, Hitech City in Hyderabad.
vSpeaking with ANI, Reddy said, "Hyderabad has made a big contribution in the sector of pharma. In different parts of the world, India exports vaccines. During the Covid-19 time, India not only vaccinated its 140 crore population but also exported vaccines to African countries and several poor nations."
The Union Minister also said that he congratulated the pharma sector, which during the Covid time helped in the production of vaccines. "In the coming days, the Modi government is ready to promote the pharma sector. The pharma sector should be encouraged and in the coming days, we will try our best to promote the sector," Reddy said.
Taking to his official X handle, Reddy posted about the IPC Expo and said, "Attended and addressed the valedictory function of the 73rd Indian Pharmaceutical Congress (IPC) in Hyderabad."
He added further, "IPC has always been a cornerstone event, bringing together thought leaders, industry experts, and innovators. In my address, emphasized how India, under the leadership of Narendra Modi, is emerging as a global pharmaceutical hub. This year's theme of IPC, 'Role of Indian Pharma for Global Wellbeing,' highlights India's significant contributions to global health."
The Union Minister also urged pharmaceutical stakeholders to strengthen Hyderabad's brand as a pharmacy of the world. In another post, he said, "With institutions like National Animal Resource Facility for Biomedical Research (NARFBR) established by the Government of India and other cutting-edge universities, Hyderabad boasts a robust research ecosystem conducive to biomedical innovation, aiming to develop India and Hyderabad as pivotal players in the global biomedical industry."
Read also: Indian pharma firms seek tax incentives to boost innovation
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd